SEC Form 4 · accession 0001144204-17-000878
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven St Peter
Director
Period of report
Jan 4, 2017
Accepted (ET)
Jan 5, 2017 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jan 4, 2017 | M | 10,000 | $2.59 | A | 145,004 | D | |
| Common Stock, par value $0.0001 per share | Jan 4, 2017 | M | 20,000 | $2.47 | A | 165,004 | D | |
| Common Stock, par value $0.0001 per share | Jan 4, 2017 | M | 20,000 | $3.11 | A | 185,004 | D | |
| Common Stock, par value $0.0001 per share | Jan 4, 2017 | M | 20,000 | $2.20 | A | 205,004 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.59 | Jan 4, 2017 | M | 10,000 | D | Mar 9, 2009 | Jun 13, 2018 | Common Stock | 10,000 | 0 | D |
| Stock Option (right to buy) | $2.47 | Jan 4, 2017 | M | 20,000 | D | Aug 5, 2009 | Aug 5, 2019 | Common Stock | 20,000 | 0 | D |
| Stock Option (right to buy) | $3.11 | Jan 4, 2017 | M | 20,000 | D | Jun 23, 2012 | Jun 23, 2021 | Common Stock | 20,000 | 0 | D |
| Stock Option (right to buy) | $2.20 | Jan 4, 2017 | M | 20,000 | D | Jun 1, 2017 | May 31, 2026 | Common Stock | 20,000 | 0 | D |